Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) Interactions
There are 321 drugs known to interact with Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)). Of the total drug interactions, 1 is major, 317 are moderate, and 3 are minor.
- View all 321 medications that may interact with Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310)
Most frequently checked interactions
View interaction reports for Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)) and the medicines listed below.
- acetaminophen
- Advil (ibuprofen)
- Alcohol (contained in alcoholic beverages) (ethanol)
- alfuzosin
- Allegra-D 24 Hour (fexofenadine / pseudoephedrine)
- amoxicillin
- amoxicillin / clavulanate
- atorvastatin / ezetimibe
- Avapro (irbesartan)
- Azithromycin Dose Pack (azithromycin)
- benzonatate
- budesonide nasal
- citalopram
- Clexane (enoxaparin)
- Coumadin (warfarin)
- cyclobenzaprine
- Equate Allergy Relief (cetirizine)
- Ethyl Alcohol (ethanol)
- finasteride
- Flonase (fluticasone nasal)
- Flonase Sensimist (fluticasone nasal)
- ipratropium nasal
- Kenalog-10 (triamcinolone)
- Lasix (furosemide)
- Lipoflavonoid (multivitamin)
- meclizine
- meloxicam
- metformin
- methylprednisolone
- Metoprolol Tartrate (metoprolol)
More about Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310))
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- Drug class: viral vaccines
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.